Day: November 11, 2020

Contango Announces Schedule for Third Quarter 2020 Earnings Release and Conference Call

HOUSTON, Nov. 11, 2020 (GLOBE NEWSWIRE) — Contango Oil & Gas Company (NYSE American: MCF) (“Contango” or the “Company”) announced today that it plans to issue its third quarter 2020 earnings release after market close on Monday, November 16, 2020. In conjunction with the release, Contango will conduct a conference call to discuss the contents of that release on Monday, November 16, 2020 at 5:00 pm Central Standard Time.Teleconference CallThose interested in participating in the earnings conference call may do so by clicking here to join and entering your information to be connected. The link becomes active 15 minutes prior to the scheduled start time, and the conference coordinator will call you. If you are not at a computer, you can join by dialing 800-309-1256, (International 1-323-347-3622) and entering participation code...

Continue reading

Lexington Realty Trust Announces Sale Of Dow Chemical Office Property

NEW YORK, Nov. 11, 2020 (GLOBE NEWSWIRE) — Lexington Realty Trust (NYSE:LXP) (“Lexington”), a real estate investment trust (REIT) focused on single-tenant industrial real estate investments, today announced that it sold its interest in the Lake Jackson, Texas office property leased to Dow Chemical for $192 million, including the assumption by the buyer of the first mortgage loan secured by the property, which had an unpaid principal balance of $179 million. In connection with the sale, Lexington anticipates it will recognize a $57 million gain on the sale.In addition, Lexington acquired a 201,784 square foot warehouse/distribution facility on 48 acres in a logistics submarket of Phoenix, Arizona for $88 million. The facility is 100% leased to a leading e-commerce company through March 2033.ABOUT LEXINGTON REALTY TRUSTLexington Realty...

Continue reading

ANGI Homeservices to Participate in Needham & Company’s Virtual Internet Services Conference

DENVER, Nov. 11, 2020 (GLOBE NEWSWIRE) — ANGI Homeservices (NASDAQ: ANGI) will attend the Needham Virtual Internet Services Conference on Monday, November 16, 2020.  Brandon Ridenour, Chief Executive Officer of ANGI Homeservices, will participate in a fireside chat at 10:00 a.m. ET.  A live webcast of this virtual fireside chat will be available to the public on Needham’s website and a replay of the webcast will be available at http://ir.angihomeservices.com/ and http://www.iac.com/Investors/.  About ANGI Homeservices Inc.ANGI Homeservices Inc. (NASDAQ: ANGI) turns home improvement jobs imagined into jobs well-done. People throughout North America and Europe rely on us to book quality home service pros across 500 different categories, from repairing and remodeling to cleaning and landscaping. Over 230,000 domestic service professionals...

Continue reading

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update

Submitted a premarket approval (PMA) to the FDA for LungFit™ PH to treat persistent pulmonary hypertension of the newborn (PPHN)Expect patient enrollment to begin next week for the acute viral pneumonia (including SARS-CoV-2) study; Patients will be treated with 150 ppm nitric oxide with LungFit™ PROLungFit™ GO nontuberculous mycobacteria (NTM) lung infection at-home pilot study expected to start in December 2020Conference call scheduled for today, November 11that 4:30 pm ETGARDEN CITY, N.Y., Nov. 11, 2020 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and gaseous NO (gNO) for the treatment of solid...

Continue reading

Arcutis Biotherapeutics to Present at the Stifel 2020 Virtual Healthcare Conference

WESTLAKE VILLAGE, Calif., Nov. 11, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Frank Watanabe, President and CEO, will present a corporate overview during the Stifel 2020 Virtual Healthcare Conference taking place November 16-18, 2020.Details for the presentation are as follows:        Stifel 2020 Virtual Healthcare Conference        Presentation Date: Wednesday, November 18, 2020        Presentation Time: 12:20 p.m. PST / 3:20 p.m. ESTThe presentation will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at https://investors.arcutis.com/events-and-presentations....

Continue reading

TELA Bio Announces Third Quarter 2020 Financial Results

MALVERN, Pa., Nov. 11, 2020 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today reported financial results for the third quarter ended September 30, 2020. Recent HighlightsReported revenue of $5.3 million for the third quarter of 2020, increasing 34% over the third quarter of 2019 Presented additional data from the BRAVO post-market study, further demonstrating a low incidence of surgical site infections and occurrences and an initial two-year hernia recurrence rate of zero Strategically added to commercial sales team and continued to educate surgeons through TELA LIVE virtual programs“I am pleased with our strong...

Continue reading

Trevi Therapeutics Announces Third Quarter 2020 Financial Results and Business Update

PRISM Trial of Haduvio™ for Severe Pruritus in Patients with Prurigo Nodularis Exceeds Halfway Enrollment MilestonePhase 2 Chronic Cough Trial in Patients with IPF Enrolled First New Subject Post-COVID-19 RestrictionsCash Position Expected to Fund Operations into the First Half of 2022NEW HAVEN, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio™ (nalbuphine ER) to treat serious neurologically mediated conditions, today announced financial results for the quarter ended September 30, 2020, as well as business updates.“We are pleased with the continued progress of our clinical development programs,” said Jennifer L. Good, President and CEO of Trevi Therapeutics. “We recently announced significant developments...

Continue reading

PDS Biotechnology Reports Financial Results for the Third Quarter 2020 and Provides Business Update

FLORHAM PARK, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced its financial results for the third quarter ended September 30, 2020 and provided a business update.Third Quarter 2020 and Recent Business HighlightsSuccessfully raised approximately $19 million via a public offering of common stock.Initiated VERSATILE-002, a Phase 2 trial of PDS0101, our investigational drug candidate, in combination with standard of care KEYTRUDA® for first-line treatment of patients with metastatic or recurrent HPV-positive head and neck cancer.Initiated a Phase 2 study of PDS0101 in combination with standard of care chemoradiotherapy...

Continue reading

Minera IRL Requested Halt of Share Trading

LIMA, Peru, Nov. 11, 2020 (GLOBE NEWSWIRE) — Minera IRL Limited (“Minera IRL” or the “Company”), (BVL:MIRL) (CSE:MIRL) announces that trading of its shares on the Canadian Securities Exchange (the “CSE”) has been halted today at the Company’s request pending the release of material news by the Company. The Lima Stock Exchange (“BVL”) has also halted trading.The Company intends to disseminate a press release describing the material news tomorrow morning.FOR FURTHER INFORMATION, PLEASE CONTACT:No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained in this news release.

Continue reading

NeoVolta NV14 Outshines the Competition with Safety, Performance and Compatibility

SAN DIEGO, Nov. 11, 2020 (GLOBE NEWSWIRE) — NEOVOLTA INC. (OTCQB: NEOV) – More and more American homes are pairing rooftop solar with a solar battery system. With utility rates constantly on the rise, storing solar power for nighttime use has become a smart investment for many households. Homeowners are also looking for blackout protection in the face of extreme weather and wildfire-related power shutdowns, especially in California.If you’re one of those homeowners looking to add a home battery system to your solar installation, here are five things you should know:Not all battery chemistry is the same. Most home solar storage systems use a lithium ion battery, the kind used in smartphones and electric cars. The problem with lithium ion is that it’s prone to thermal runaway, in which the battery rapidly overheats and combusts, potentially...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.